Literature DB >> 24523511

Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamics.

Barney S Graham1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24523511      PMCID： PMC4038969          DOI： 10.1093/infdis/jiu075

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  11 in total

1.  Editorial commentary: respiratory syncytial virus: a global pathogen in an aging world.

Authors:  Ann R Falsey
Journal:  Clin Infect Dis       Date:  2013-07-21       Impact factor: 9.079

2.  Respiratory syncytial virus and recurrent wheeze.

Authors:  Maarten O Blanken; Maroeska M Rovers; Louis Bont
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

3.  Mortality from HIV in the Global Burden of Disease study - authors' reply.

Authors:  Rafael Lozano; Katrina F Ortblad; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

4.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

5.  Respiratory syncytial virus infections within families.

Authors:  C B Hall; J M Geiman; R Biggar; D I Kotok; P M Hogan; G R Douglas
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

6.  Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness.

Authors:  Marie-Pierre Préziosi; M Elizabeth Halloran
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

7.  Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors: 
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

8.  High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.

Authors:  N Lee; G C Y Lui; K T Wong; T C M Li; E C M Tse; J Y C Chan; J Yu; S S M Wong; K W Choi; R Y K Wong; K L K Ngai; D S C Hui; P K S Chan
Journal:  Clin Infect Dis       Date:  2013-07-21       Impact factor: 9.079

9.  Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

Authors:  Marc Baguelin; Stefan Flasche; Anton Camacho; Nikolaos Demiris; Elizabeth Miller; W John Edmunds
Journal:  PLoS Med       Date:  2013-10-08       Impact factor: 11.069

10.  The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya.

Authors:  Patrick K Munywoki; Dorothy C Koech; Charles N Agoti; Clement Lewa; Patricia A Cane; Graham F Medley; D J Nokes
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226
View more
  14 in total

1.  Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.

Authors:  Ryan F Russell; Jacqueline U McDonald; Maria Ivanova; Ziyun Zhong; Alexander Bukreyev; John S Tregoning
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

2.  Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households.

Authors:  Samuel Pc Brand; Patrick Munywoki; David Walumbe; Matthew J Keeling; David James Nokes
Journal:  Elife       Date:  2020-03-27       Impact factor: 8.140

3.  Characterizing the risk of respiratory syncytial virus in infants with older siblings: a population-based birth cohort study.

Authors:  P Jacoby; K Glass; H C Moore
Journal:  Epidemiol Infect       Date:  2016-11-08       Impact factor: 4.434

4.  Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings.

Authors:  Piero Poletti; Stefano Merler; Marco Ajelli; Piero Manfredi; Patrick K Munywoki; D Nokes; Alessia Melegaro
Journal:  BMC Med       Date:  2015-03-10       Impact factor: 8.775

5.  Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting.

Authors:  Timothy M Kinyanjui; Thomas A House; Moses C Kiti; Patricia A Cane; David J Nokes; Graham F Medley
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

6.  Transmission of respiratory syncytial virus infection within families.

Authors:  Terho Heikkinen; Heikki Valkonen; Matti Waris; Olli Ruuskanen
Journal:  Open Forum Infect Dis       Date:  2015-01-03       Impact factor: 3.835

7.  Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.

Authors:  Joyce U Nyiro; Charles Sande; Martin Mutunga; Patience K Kiyuka; Patrick K Munywoki; J Anthony G Scott; D James Nokes
Journal:  Vaccine       Date:  2015-02-26       Impact factor: 3.641

8.  Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.

Authors:  Joyce Uchi Nyiro; Charles Jumba Sande; Martin Mutunga; Patience Kerubo Kiyuka; Patrick Kioo Munywoki; John Anthony G Scott; David James Nokes
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

9.  Transmission of Respiratory Syncytial Virus Among Children Under 5 Years in Households of Rural Communities, the Philippines.

Authors:  Hirono Otomaru; Taro Kamigaki; Raita Tamaki; Michiko Okamoto; Portia Parian Alday; Alvin Gue Tan; Joanna Ina Manalo; Edelwisa Segubre-Mercado; Marianette Tawat Inobaya; Veronica Tallo; Socorro Lupisan; Hitoshi Oshitani
Journal:  Open Forum Infect Dis       Date:  2019-03-11       Impact factor: 3.835

10.  Risk of Transmission and Viral Shedding From the Time of Infection for Respiratory Syncytial Virus in Households.

Authors:  Hirono Otomaru; Johanna Beulah T Sornillo; Taro Kamigaki; Samantha Louise P Bado; Michiko Okamoto; Mariko Saito-Obata; Marianette T Inobaya; Edelwisa Segubre-Mercado; Portia P Alday; Mayuko Saito; Veronica L Tallo; Beatriz P Quiambao; Hitoshi Oshitani; Alex R Cook
Journal:  Am J Epidemiol       Date:  2021-12-01       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.